iMD Companies, Inc. (ICBU)
USD 0.0
(12.5%)
USD 0.0
(12.5%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.1 Million USD | 2.67% |
| 2022 | 1.07 Million USD | 23.48% |
| 2021 | 870.57 Thousand USD | 151.61% |
| 2020 | 346 Thousand USD | -5.57% |
| 2019 | 366.4 Thousand USD | 103.79% |
| 2018 | 179.79 Thousand USD | -90.03% |
| 2017 | 1.8 Million USD | -0.26% |
| 2016 | 1.8 Million USD | 244.95% |
| 2015 | 524.2 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.15 Million USD | 3.56% |
| 2024 Q1 | 1.11 Million USD | 1.44% |
| 2023 FY | 1.1 Million USD | 2.67% |
| 2023 Q4 | 1.1 Million USD | -1.13% |
| 2023 Q1 | 1.08 Million USD | 0.73% |
| 2023 Q2 | 1.1 Million USD | 1.66% |
| 2023 Q3 | 1.11 Million USD | 1.4% |
| 2022 Q1 | 937.77 Thousand USD | 7.72% |
| 2022 FY | 1.07 Million USD | 23.48% |
| 2022 Q4 | 1.07 Million USD | 4.44% |
| 2022 Q2 | 1.02 Million USD | 9.45% |
| 2022 Q3 | 1.02 Million USD | 0.28% |
| 2021 Q2 | 687.05 Thousand USD | 53.43% |
| 2021 FY | 870.57 Thousand USD | 151.61% |
| 2021 Q1 | 447.8 Thousand USD | 0.0% |
| 2021 Q4 | 870.57 Thousand USD | 22.78% |
| 2021 Q3 | 709.05 Thousand USD | 3.2% |
| 2020 FY | 346 Thousand USD | -5.57% |
| 2019 FY | 366.4 Thousand USD | 103.79% |
| 2018 FY | 179.79 Thousand USD | -90.03% |
| 2017 FY | 1.8 Million USD | -0.26% |
| 2016 FY | 1.8 Million USD | 244.95% |
| 2015 FY | 524.2 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -18294.433% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | 14.94% |
| Biocept, Inc. | 10.37 Million USD | 89.362% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | 97.849% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 98.197% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -102.017% |
| IDenta Corp. | 428.17 Thousand USD | -157.76% |
| Interpace Biosciences, Inc. | 4.24 Million USD | 73.989% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | -297.002% |
| NovelStem International Corp. | 3.32 Million USD | 66.803% |
| Optigenex Inc. | 4.42 Million USD | 75.07% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | 32.332% |
| Response Genetics, Inc | 4.91 Million USD | 77.559% |
| Rennova Health, Inc. | 359.19 Thousand USD | -207.263% |
| RushNet, Inc. | 4.25 Million USD | 74.046% |
| ScreenPro Security Inc. | 249.05 Thousand USD | -343.15% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | -38.228% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | -91.482% |
| Todos Medical Ltd. | 33 Million USD | 96.656% |